<<Termeer also would get a cash change-in-control payment of $11 million. So he would pocket $29 million if Genzyme accepts the $69-a-share offer. However, he would lose $38 million in the present value of three year’s future pay and so would end up $9 million in the hole.>>
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.